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Abstract
Effective triage of dengue patients early in the disease course for in- or out-patient manage-
ment would be useful for optimal healthcare resource utilization while minimizing poor clini-
cal outcome due to delayed intervention. Yet, early prognosis of severe dengue is
hampered by the heterogeneity in clinical presentation and routine hematological and bio-
chemical measurements in dengue patients that collectively correlates poorly with eventual
clinical outcome. Herein, untargeted liquid-chromatography mass spectrometry metabolo-
mics of serum from patients with dengue fever (DF) and dengue hemorrhagic fever (DHF) in
the febrile phase (<96 h) was used to globally probe the serum metabolome to uncover
early prognostic biomarkers of DHF. We identified 20 metabolites that are differentially
enriched (p<0.05, fold change >1.5) in the serum, among which are two products of trypto-
phan metabolism–serotonin and kynurenine. Serotonin, involved in platelet aggregation
and activation decreased significantly, whereas kynurenine, an immunomodulator,
increased significantly in patients with DHF, consistent with thrombocytopenia and immuno-
pathology in severe dengue. To sensitively and accurately evaluate serotonin levels as
prognostic biomarkers, we implemented stable-isotope dilution mass spectrometry and
used convalescence samples as their own controls. DHF serotonin was significantly 1.98
fold lower in febrile compared to convalescence phase, and significantly 1.76 fold lower
compared to DF in the febrile phase of illness. Thus, serotonin alone provided good prog-
nostic utility (Area Under Curve, AUC of serotonin = 0.8). Additionally, immune mediators
associated with DHF may further increase the predictive ability than just serotonin alone.
Nine cytokines, including IFN-γ, IL-1β, IL-4, IL-8, G-CSF, MIP-1β, FGF basic, TNFα and
RANTES were significantly different between DF and DHF, among which IFN-γ ranked top
by multivariate statistics. Combining serotonin and IFN-γ improved the prognosis
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performance (AUC = 0.92, sensitivity = 77.8%, specificity = 95.8%), suggesting this duplex
panel as accurate metrics for the early prognosis of DHF.
Author Summary
Dengue, an acute arboviral disease has emerged globally, inflicting debilitating symptoms
in 96 million people. The early prediction of severe dengue (dengue hemorrhagic fever,
DHF) is challenging due to varied and late-presenting symptoms, requiring frequent mon-
itoring for signs of disease progression. An often used parameter to monitor disease pro-
gression is decrease in platelet count, or thrombocytopenia, which is a feature of DHF.
However, whether platelet-derived compounds are useful as early biomarkers predictive of
DHF has not been investigated. In this study, we investigated the utility of serum metabo-
lites as predictive biomarkers. We developed quantitative and high-throughput tools and
discovered circulating serotonin, conceivably platelet-derived, that showed a nearly two-
fold decrease in DHF patients compared to mild dengue fever. Because immune mediators
may increase the predictive ability, we measured them in blood and identified interferon-
gamma as an important cytokine in DHF. When serotonin is used in combination with
IFN-γ, this dual-panel predictive panel provides accurate prognosis of DHF within 96 h
from fever onset. These findings may have important clinical implications not just in early
dengue prognostication but also in the design of therapeutic strategies against dengue
infections.
Introduction
Dengue is arguably the most important arboviral disease globally, with an estimated 390 mil-
lion infections occurring yearly, of which nearly 100 million are clinically apparent [1]. The
clinical manifestations of dengue infections range from mild undifferentiated febrile illness to
classical dengue fever (DF), severe dengue hemorrhagic fever (DHF) and sometimes fatal dis-
ease. The two predominant pathophysiologic observations in DHF are increased vascular per-
meability and thrombocytopenia, which result in plasma leakage and increased risk of
hemorrhage, respectively. Early triage in the acute, febrile phase is useful for streamlining case
management and monitoring.
One of the pathophysiological hallmarks of severe dengue is increased vascular permeabil-
ity, leading to a loss in blood volume that if uncorrected, could lead to shock. The degree of
plasma leakage varies and prediction of severe plasma leakage has been challenging [2]. Daily
or even more frequent monitoring of hematocrit levels may be required for at least 2–3 days
around the period of fever defervescence to detect plasma leakage soon after its onset. As timely
fluid support prevents progression of plasma leakage to hypovolemic shock and multi-organ
failure, tools that enable triaging of patients according to disease outcome could enable a more
effective use of limited healthcare resources, especially during dengue epidemics [3]. Indeed,
the components of early pathophysiological mechanisms could serve as reliable prognostic fac-
tors given their mechanistic role in disease manifestation.
It is generally believed that the observed pathophysiology is immune-mediated brought
about by monocytes, T-cells, endothelial cells, mast cells and increasingly platelets, as well as
the interactions between these cell types [4–7]. Despite the consistent presence of thrombocy-
topenia in the acute stages of dengue, little research has focused on the pathologic contribution
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of platelet-derived soluble factors in DHF progression and their use as prognostic markers.
Platelets circulate in high numbers throughout the system and upon activation release their
granule contents to exert their hemostatic, immunological and inflammatory effects [8,9].
DENV has been reported to activate platelets [6]. One of these bioactive compounds released
during platelet activation is serotonin (5-hydroxytryptamine or 5-HT). Platelets store seroto-
nin in the dense granules but lack the enzymes to synthesize serotonin. Instead, platelets take
up plasma serotonin produced by enterochromaffin cells in the gastrointestinal tract, through
the serotonin receptor (SERT or 5-HTT) [10]. Serotonin is secreted during platelet activation
and promotes platelet aggregation. It also further amplifies platelet activation and aggregation
through 5-HT2A receptor re-uptake to result in vasoconstriction of surrounding blood vessels
and hemostasis [11]. While in vitro results suggest DENV induced platelet apoptosis [6], the
reduction of platelet number and function has not been characterized in vivo. Furthermore,
thrombocytopenia and associated platelet dysfunction is short-lived and the rapid recovery of
platelet numbers in the convalescence phase suggest that the function of soluble metabolites
and/or immune mediators with short half lives may play critical roles in disease progression.
In this study, we adopted a metabolomics to study dengue-induced metabolites, especially
platelet-derived molecules and evaluated their potential as prognostic biomarkers for severe
dengue. We discovered a major reduction in circulating serotonin in both DF and DHF, with
the reduction in DHF exceeding that of DF. In addition, serotonin levels correlated with the
degree of thrombocytopenia, and when used in combination with IFN-γ, they provide accurate
early (<96 h from onset of fever) prognosis of DHF.
Methods
Patient enrollment
The dengue study cohort of 116 dengue patients– 60 DF patients and 56 DHF patients
(Table 1) were recruited from the Prospective Adult Dengue Study (PADS) [12]. Briefly, PADS
is a cohort study of acutely febrile adults at a tertiary care center, Communicable Diseases Cen-
ter, Tan Tock Seng Hospital, Singapore. Adult patients ( 18 years) presenting with acute
onset of fever ( 37.5°C) without rhinitis or other clinical alternatives were included in the
study (Febrile stage,< 96 hours post onset of fever; Defervescence, Day 5–7, Convalescence,
Day 21–28). Venous blood samples were collected, aliquoted and frozen at -80°C for hemato-
logical, virological and serological analysis. Enrollment of all eligible individuals was based on
written informed consent and the collected samples were anonymized. The protocols were
approved by the Domain Specific Review Board of the National Healthcare Group, Singapore
(DSRB/E/2009/432). We reported our study design, hypotheses, patient characteristics, assay
methods, statistical methods and modeling methods as per REMARK which is important for
generalizability [13]. Additionally we used serum samples from 24 asymptomatic age- and gen-
der-matched healthy subjects as controls. DF and DHF patients were classified according to
the WHO 1997 dengue guidelines [14]. To fulfill the case definition of DHF, all four of the fol-
lowing criteria must be present, namely: fever or history of fever, hemorrhagic tendencies,
thrombocytopenia and evidence of plasma leakage [14]. Hematoconcentration was determined
by the hematological analyzer and expressed as % of the volume of whole blood that was made
up of red blood cells. Hematocrit increase of over 20% of the values at convalescence phase is
considered a common clinical index of plasma leakage and DHF diagnosis. The PADS cohort
comprised of both DF and DHF patients recruited at different phases of dengue infection–
(febrile phase: DF = 25; DHF = 27; defervescence phase: DF = 31; DHF = 29, convalescence
phase: DF = 25; DHF = 25). DENV2 is the predominant DENV type. Based on the anti-DENV
IgG and IgM seropositivity or seronegativitiy, immune status of the patients was determined.
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Anti-DENV IgM seropositivity and IgG seronegativity indicated that 40–52% of DF and 22–
41% of DHF are primary cases, and the remaining secondary cases. 12–16% DF patients and
59–76% DHF patients had platelets<50×103/μL at any point as determined during their daily
routine total blood count.
Hematological, serological and virological analysis
A detailed hematological and virological analysis was performed and included white blood cell
count (WBC), red blood cell count (RBC), blood hemoglobin (HGB), hematocrit (HCT), mean
corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemo-
globin concentration (MCHC), platelet count (PLT), lymphocyte percentage (LYMPH%), lym-
phocyte count (LYMPH), mixed cell count (MXD), neutrophil percentage (NEUT%),
neutrophil count (NEUT), red blood cell distribution width-coefficient of variation
Table 1. Patient characteristics and demographics.
Phase Characteristic DF DHF
Febrile N 25 27
Mean age (range), y 33.9 (21–44) 40.8 (22–67)
Average fever days 3.5 3.6
Primary infection (%) 10 (40) 6 (22)
Secondary infection (%) 15 (60) 21 (78)
Serotype 1 3 2
Serotype 2 22 22
Serotype 3 0 1
Serotype 4 0 2
<50k Platelets (%) 0 (0%) 3 (11%)
Mean platelet count (x10^3/μL) 118.0 87.0
Defervescence N 31 29
Mean age (range), y 34.9 (25–56) 37.7 (20–64)
Average fever days 5.4 5.6
Primary infection (%) 16 (52) 12 (41)
Secondary infection (%) 15 (48) 17 (59)
Serotype 1 5 3
Serotype 2 24 22
Serotype 3 2 3
Serotype 4 0 1
<50k Platelets (%) 3 (10) 6 (21)
Mean platelet count (x10^3/μL) 101.5 75.9
Convalescence N 25 25
Mean age (range), y 35.9 (21–49) 37.4 (20–59)
Average fever days 26.2 26.0
Primary infection (%) 10 (40) 7 (28)
Secondary infection (%) 15 (60) 18 (72)
Serotype 1 2 3
Serotype 2 23 17
Serotype 3 0 2
Serotype 4 0 3
<50k Platelets (%) 0 (0) 0 (0)
Mean platelet count (x10^3/μL) 218.2 218.2
doi:10.1371/journal.pntd.0004607.t001
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(RDW-CV), and quantitation of peripheral viral titers using reverse transcriptase-polymerase
chain reaction (RT-PCR) crossover values (Ct). Dengue viral infection was confirmed by
RT-PCR [15], or NS1 detection by Dengue NS1 Ag Strip (Bio-Rad, Marnes-la-Coquette,
France) at the Environmental Health Institute, Singapore, or typing by virus isolation and
immunofluorescence using DENV type-specific monoclonal antibodies (ATCC: HB46-49).
Dengue-immune status (primary or secondary DENV infection) was based on Dengue IgG lev-
els in the acute sera, using a commercially obtained ELISA (PanBio, Brisbane, Australia)
according to the manufacturer’s protocol.
Sample preparation
For untargeted metabolomics analysis, a volume of 50 μL from each serum sample was
thawed at 4°C and serum proteins were precipitated with 200 mL ice-cold methanol, which
contained 10 mg/mL 9-fluorenylmethoxycarbonyl-glycine as an internal standard. After
vortexing, the mixture was centrifuged at 16,000 rpm for 10 minutes at 4°C and the superna-
tant was collected and evaporated to dryness in a vacuum evaporator. The dry extracts were
then redissolved in 200 μL of 98:2 water/methanol for liquid chromatography-mass spec-
trometry (LC-MS) analysis. Quality control (QC) samples were prepared by mixing equal
amounts of serum samples from all the samples and processed as per other samples. The QC
sample was run after each 8 samples to monitor the stability of the system and all samples
were randomized.
For targeted metabolomics analysis, sample preparation followed a published report with
some modifications [16]. Briefly, 10 μL of the internal standard mix was added to 50 μL of
serum. The sample was then diluted to 100 μL with water containing 0.1% formic acid (v/v),
vortexed, followed by the addition of 400 μL of cold methanol. After vortexing, the mixture
was centrifuged at 16,000 rpm for 10 minutes at 4°C and the supernatant was collected and
evaporated to dryness in a vacuum evaporator. The dry extracts were then redissolved in
200 μL of 0.1% formic acid in water for LC-MS/MS analysis. A summary of the workflow uti-
lized in untargeted and targeted metabolomics studies is shown in S1 Fig.
Relative quantification by untargeted metabolomics
Untargeted metabolomics were performed as previously described with modifications [17].
The supernatant fraction from sample preparation step was analyzed using Agilent 1290 ultra-
high pressure liquid chromatography system (Waldbronn, Germany) equipped with a 6520
QTOF mass detector managed by a MassHunter workstation. The column used for the separa-
tion was an Agilent rapid resolution HT Zorbax SB-C18 (2.1×100 mm, 1.8 mm; Agilent Tech-
nologies, Santa Clara, CA, USA). The oven temperature was set at 45°C. The gradient elution
involved a mobile phase consisting of (A) 0.1% formic acid in water and (B) 0.1% formic acid
in methanol. The initial condition was set at 5% B. A 7 min linear gradient to 70% B was
applied, followed by a 12 min gradient to 100% B which was held for 3 min, then returned to
starting conditions over 0.1 min. Flow rate was set at 0.4 ml/min, and 5 mL of samples was
injected. The electrospray ionization mass spectra were acquired in both positive and negative
ion mode. Mass data were collected between m/z 100 and 1000 at a rate of two scans per sec-
ond. The ion spray voltage was set at 4,000 V, and the heated capillary temperature was main-
tained at 350°C. The drying gas and nebulizer nitrogen gas flow rates were 12.0 L/min and
50 psi, respectively. Two reference masses were continuously infused to the system to allow
constant mass correction during the run: m/z 121.0509 (C5H4N4) and m/z 922.0098
(C18H18O6N3P3F24).
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Absolute quantification by targeted metabolomics
The targeted LC-MS/MS analysis followed a published report with some modifications [16].
Briefly, LC-MS analysis was performed with Agilent 1290 ultrahigh pressure liquid chromatog-
raphy system (Waldbronn, Germany) coupled to an electrospray ionization with iFunnel Tech-
nology on a triple quadrupole mass spectrometer. Chromatographic separation was achieved
by using Atlantis T3 column (2.1×100 mm, 3 μm;Waters, Eschbornn, Germany) with mobile
phases (A) 0.1% formic acid in water and (B) 0.1% formic acid in methanol. The initial condi-
tion was set at 0% B. A 10 min linear gradient to 40% B was applied, followed by 1 min gradient
to 100% B which was held for 5 min, then returned to starting conditions over 0.1 min. The col-
umn was kept at 40°C and the flow rate was 0.4 mL/min. The auto-sampler was cooled at 4°C
and an injection volume of 5 μL was used. Electrospray ionization was performed in positive
ion mode with the following source parameters: drying gas temperature 200°C with a flow of
14 L/min, nebulizer gas pressure 30 psi, sheath gas temperature 400°C with a flow of 11 L/min,
capillary voltage 3,000 V and nozzle voltage 800 V. Compounds were quantified in multiple
reaction monitoring (MRM) mode with the following transitions:m/z 177>160,m/z 181>164,
m/z 209>192,m/z 213>196,m/z 233>174,m/z 192>146, andm/z 213>196 for serotonin, d4-
serotonin, kynurenine, and d4-kynurenine, melatonin, 5-hydroxy-indole-3-acetic acid (HIAA),
and 5-hydroxytryptophan (HTP), respectively. Data acquisition and processing were per-
formed using MassHunter software (Agilent Technologies, US). A representative LC-MS/MS
chromatogram of a native standards mix is shown in S2 Fig.
The method was validated for limit of detection (LOD), linearity, accuracy, precision and
recovery, according to Food and Drug Administration (FDA) guidelines for biological method
as previous published report [16]. Briefly, the calibration curves were constructed from three
replicate measurements of eight concentrations of each standard. A linear regression with r2
>0.995 was obtained in all relevant ranges. The LODs, defined by a signal-to-noise ratio (S/N)
of 3, ranged from 0.5 to 10.0 nM for all the analytes. The recoveries were evaluated by spiking
defined amounts of analytes into aliquots of unprocessed serum and analyte concentrations
were calculated using the calibration curves. The spiked concentration was obtained by sub-
tracting the endogenous concentration which was determined from the analysis of the
unspiked sample. The recoveries generally ranged from 52.4% to 82.6%. For intra-batch and
inter-batch precision and accuracy, the relative standard deviation (RSD) values ranged from
1.1% to 13.2% all the analytes.
Cytokine analysis
Fluorescent bead based measurement of cytokines, chemokines and growth factors in the
patients’ sera were performed in duplicates using the Luminex technology xMAP (Bioplex
27-plex human cytokine kit, Bio-Rad, California, USA) as per manufacturer’s instructions. The
measured analytes are IL-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13,
IL-15, IL-17, basic FGF, Eotaxin, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1 (MCAF), MIP-1α,
MIP-1β, PDGF-BB, RANTES, TNF-α and VEGF. The standard curves were optimized auto-
matically by the software (Bioplex manager) and verified manually. In order to prevent batch
effect, samples were randomized prior to analysis. Calibrations and validations were performed
prior to analyses.
Data analysis
Raw spectrometric data in untargeted metabolomics were analyzed by MassHunter Qualitative
Analysis software (Agilent Technologies, US) and the molecular features characterized by
retention time (RT), chromatographic peak intensity and accurate mass, were obtained by
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using the Molecular Feature Extractor algorithm. The features were then analyzed by Mas-
sHunter Mass Profiler Professional software (Agilent Technologies, US). Only features with an
intensity 20,000 counts (approximately three times the limit of detection of our LC-MS
instrument), and found in at least 80% of the samples at the same sampling time point signal
were kept for further processing. Next, a tolerance window of 0.15 min and 2 mDa was used
for alignment of RT andm/z values, and the data normalized to spiked 9-fluorenylmethoxycar-
bonyl-glycine internal standard. Raw spectrometric data in targeted metabolomics were pro-
cessed using MassHunter Workstation Quantitative Analysis software (Agilent Technologies,
US).
For statistical analysis, nonparametric Test (Wilcoxon, Mann–Whitney test) with Benja-
mini-Hochberg Multiple Testing Correction was employed, because the samples analyzed were
obtained from different patients, and statistical significance was set at p<0.05. For multivariate
data analysis using hierarchical clustering or Orthogonal projections to latent structures dis-
criminant analysis (OPLS-DA), data were normalized by median-centering and dividing by
standard deviation. Hierarchical clustering was performed using MeV version 4.9.0. OPLS-DA
was performed using the software package SIMCA-P 13.0 version (Umetrics AB, Umea, Swe-
den). Metabolites and cytokines/chemokines with Variable Importance in the Projection (VIP)
values>1 were considered to be influential for the separation of samples in OPLS-DA analysis.
In addition, the fold change (FC) analysis was also performed to further filter the features and
only those features with FC> 1.5 were selected as potential significantly altered metabolites.
Receiver operating characteristic (ROC) curve was made by using R package.
Compound identification
The structure identification of the differential metabolites was based on our published work
[17]. Briefly, the elemental compositions of the metabolites were first calculated based on the
exact mass, the nitrogen rule and the isotope pattern by Masshunter software from Agilent.
Then, the elemental composition and exact mass were used for open source database searching,
including LIPIDMAPS (http://www.lipidmaps.org/), HMDB (http://www.hmdb.ca/), METLIN
(http://metlin.scripps.edu/) and MassBank (http://www.massbank.jp/). Next, MS/MS experi-
ments were performed to obtain structural information via the interpretation of the fragmenta-
tion pattern of the metabolite. The MS/MS spectra of possible metabolite candidates in the
databases were also searched and compared. Finally, the metabolites were confirmed by com-
parison with the standards where commercially available, which was the case for serotonin and
kynurenine. The metabolites are listed according to the minimum reporting standards for
chemical analysis in metabolomics recommended by Metabolomics Standard Initiative (MSI)
[18,19]. Briefly, a four-level system ranging from Level 1 (identified metabolites) via Levels 2
and 3 (putatively annotated compounds and compound classes) to Level 4 (unidentified or
unclassified metabolites which can still be differentiated based on spectrum data).
Results
Global-scale metabolomics revealed early changes in serum
metabolome associating with platelet numbers in DHF patients
We characterized the metabolome changes early in dengue infections using liquid-chromatog-
raphy tandem mass spectrometry (LC-MS/MS) to globally map the serum metabolomes from
DF (n = 25) and DHF (n = 27) patients. In this untargeted, global metabolomics, a total of 20
MSI Levels 1 and 2 metabolites were significantly different between DHF and DF patients in
the febrile phase, of which 8 were increased [(L-kynurenine, 13E-docosenamide, deoxyinosine,
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N-Heptanoylglycine, 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid, bilirubin, phospho-
tidylethanolamine (20:4/20:3), phosphatidylserine (18:0/18:0) and 12 were decreased (Leucyl-
phenylalanine, phenylalanyl-tryptophan, leucyl-alanine, palmitic amide, serotonin, oleamide,
phenylalanylphenylalanine, lysophosphotidylethanolamine (20:0/0:0), lysophosphotidyletha-
nolamine (22:4/0:0), phosphatidylserine (18:0/20:0), phosphotidylethanolamine (20:4/P-18:1),
phosphotidylethanolamine (18:1/22:5)] in DHF patients relative to DF patients (Table 2). MSI
Levels 3 and 4 metabolites were listed in S1 Table. Hierarchical clustering based on the metabo-
lome profile optimally segregated the patients (Fig 1), where all but four DF patients and three
DHF patients were classified separately, therefore correlating well with WHO 1997 dengue
classification scheme. Verification of peaks’ retention time and MS/MS spectrum through the
use of synthetic standards provided highly confident identification of serotonin and kynure-
nine. Among the hematological parameters that are routinely tested in the clinics, platelets cor-
related most frequently with the metabolites, in particular, demonstrating significant positive
correlations to serotonin (r = 0.67; p<0.0001) and negative correlations to kynurenine (r = ‒
0.45; p<0.005) (Fig 2). Decrease in serotonin levels was accompanied with an increase in
kynurenine levels in the febrile phase (Fig 3A and 3B). An increase in indoleamine 2,3-dioxy-
genase in DF patients was reported previously [20], and is presumably the source of
kynurenine.
Determination of Serotonin and Kynurenine levels across the time-
course of dengue infection
We further evaluated serotonin and kynurenine levels in order to better understand their levels
across the course of dengue infection. To improve analytical specificity for absolute
Table 2. Identified differential metabolites between DF and DHF patients in the febrile phase of infection.
HMDB Accurate
mass
Metabolite Chemical
formula
p
value
Fold change (DHF/
DF)
Pathway
HMDB00684 208.0817 L-Kynurenine C10H12N2O3 0.001 1.7 Tryptophan metabolism
HMDB29006 351.1524 phenylalanyl-tryptophan C20H21N3O3 0.007 0.57 Dipeptide
HMDB02117 281.2677 oleamide C18H35NO 0.002 0.23 Fatty acid amide
HMDB13243 278.1582 Leucyl-phenylalanine C15H22N2O3 0.02 0.39 Dipeptide
HMDB00583 337.3271 Docosenamide C22H45NO 0.02 3.49 Fatty acid amide
HMDB00071 252.0814 Deoxyinosine C10H12N4O4 0.005 1.7 Purine metabolism
HMDB28922 202.1268 Leucyl-Alanine C9H18N2O3 0.01 0.43 Dipeptide
HMDB00259 176.0928 Serotonin C10H12N2O 0.004 0.64 Tryptophan metabolism
HMDB12273 255.2517 Palmitic amide C16H33NO 0.002 0.16 Fatty acid amide
HMDB12378 791.558 PS (18:0/18:0) C42H82NO10P 0.0001 1.62 Glycerophospholipid
HMDB13302 312.1486 Phenylalanylphenylalanine C18H20N2O3 0.02 0.61 Dipeptide
HMDB00054 584.2643 Bilirubin C33H36N4O6 0.02 1.58 Porphyrin and chlorophyll
metabolism
HMDB61112 240.1017 CMPF C12H16O5 0.03 1.59 Fatty acid
HMDB11523 529.3201 LPE(22:4/0:0) C27H48NO7P 0.02 0.66 Glycerophospholipid
HMDB09044 791.5411 PE(18:1/22:5) C45H78NO8P 0.02 0.57 Glycerophospholipid
HMDB09397 789.5349 PE (20:4/20:3) C45H76NO8P 0.009 1.54 Glycerophospholipid
HMDB09414 749.5394 PE(20:4/P-18:1) C43H76NO7P 0.007 0.69 Glycerophospholipid
HMDB11511 509.3548 LPE(20:0/0:0) C25H52NO7P 0.01 0.72 Glycerophospholipid
HMDB10164 819.6028 PS(18:0/20:0) C44H86NO10P 0.02 0.71 Glycerophospholipid
HMDB13010 187.1177 N-Heptanoylglycine C9H17NO3 0.009 2.07 Acylglycine
doi:10.1371/journal.pntd.0004607.t002
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Fig 1. Hierarchical heatmap clustering with identified differential metabolites segregates febrile
phase dengue fever (DF) and dengue hemorrhagic fever (DHF) patients. Each column shows ion
intensity for a specific metabolite after mean centering and unit variance scaling of the data. Each row shows
the serummetabolic profiles of DF and DHF patients.
doi:10.1371/journal.pntd.0004607.g001
Fig 2. Pearson correlation analysis reveals correlation of platelets with serotonin and kynurenine in
the febrile phase of infection. (A) Positive correlation between platelet and serotonin (r = 0.67; p<0.0001).
(B) Negative correlation between platelet and kynurenine (r = ‒0.45; p<0.005). DF—dengue fever; DHF—
dengue hemorrhagic fever.
doi:10.1371/journal.pntd.0004607.g002
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quantitative determinations, we developed a high-throughput precision assay based on stable-
isotope dilution mass spectrometry of serotonin and kynurenine. Using defined concentrations
of deuterated internal standards spiked into samples and calculating the response ratio of the
analyte of interest to the internal standard, we accurately determined the concentrations of
serotonin and kynurenine in DF and DHF patients (Fig 4A and 4B). Table 3 summarizes the
mean values of serotonin and kynurenine (nM) at the three phases in DF and DHF patients.
Compared to DF patients, we observed significant decreases in serotonin in DHF patients in
both the febrile (p<0.001) and the defervescence phases (p<0.001), but not the convalescence
phase. Kynurenine on the other hand was significantly different between DF and DHF patients
in the febrile phase (p<0.01), but not in the defervescence and convalescence phases. Further-
more, a dynamic change of serotonin levels was observed in both DF and DHF patients in all
three phases of infection. Compared to febrile stage, the level of serotonin continued to
decrease and reached the lowest level at defervescence phase. At convalescence phase, increased
serotonin was observed and the level was significantly higher than the levels in both febrile and
defervescence phases. Meanwhile, there was no difference in serotonin levels between cases of
primary and secondary infection in all three phases (S3 Fig).
Similar to the correlation results in global-scale metabolomics (Fig 2), significant positive
correlation between serotonin concentrations and platelet numbers (r = 0.55, p = 0.0070 (DF)
and r = 0.67, p = 0.0001 (DHF); S4A Fig) was observed in the febrile phase, suggesting that the
decrease in serotonin is associated with decreased platelet numbers in DF and DHF patients.
Interestingly, the correlation between serotonin and platelets ceased in the defervescence phase
(r = 0.20, p>0.05; S4B Fig). If serotonin levels and platelet counts were organized according to
different fever days of dengue patients, serotonin levels continued to decrease from onset of
fever up to Day 6 and 7 (S4C Fig), which did not parallel the initial decrease then recovery of
platelet numbers with time (S4D Fig).
The levels of HIAA and melatonin, two main degradation products of serotonin, and HTP,
the precursor of serotonin, were also evaluated, by using d4-serotonin as their internal
Fig 3. Serum serotonin and kynurenine changes in dengue patients in the febrile phase of infection. (A) Elevated change trend of kynurenine from
Control, dengue fever (DF) to dengue hemorrhagic fever (DHF). (B) Decreased change trend of serotonin from Control, dengue fever (DF) to dengue
hemorrhagic fever (DHF). Mean value (middle lines) ± standard deviation (SD, error bars) is reported. Significance is indicated as *,p<0.05; **,p<0.01; ***,
p< 0.001 by Mann-Whitney test.
doi:10.1371/journal.pntd.0004607.g003
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Fig 4. Temporal profile of circulating serotonin and kynurenine in the three main phases of dengue.
Temporal profiles of (A) serotonin and (B) kynurenine across the febrile (1–4 d), defervescence (5–7 d) and
convalescence (21–28 d) phases. Mean value (middle lines) ± standard deviation (SD, error bars) is reported.
Significance is indicated as *, p<0.05; **, p<0.01; ***, p<0.001 by MannWhitney test. DF—dengue fever;
DHF—dengue hemorrhagic fever.
doi:10.1371/journal.pntd.0004607.g004
Table 3. Serum serotonin and kynurenine concentrations in DF and DHF patients.
Phase* Serotonin (mean ± SD, nM) Kynurenine (mean ± SD, nM)
DF DHF DF DHF
Febrile 309 ± 127 175 ± 88 3470± 953 4518± 1336
Defervescence 231 ± 99 117 ± 102 3597 ± 1166 3613± 993
Convalescence 386 ± 131 349. ± 148 1764± 354 1789± 456
* Febrile, DF = 25, DHF = 27; Defervescence, DF = 31, DHF = 29; Convalescence, DF = 25, DHF = 25
doi:10.1371/journal.pntd.0004607.t003
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standard. While the levels of melatonin in serum were below the detection limit, the concentra-
tions of HTP and HIAA in DF and DHF patients were determined (S5A and S5B Fig). Unlike
serotonin, neither HTP nor HIAA showed any significant difference between DF and DHF in
both the febrile and the defervescence phases.
Serotonin and IFN-γ as early prognosis biomarkers of DHF
Given the early significant changes of serotonin and kynurenine in DHF patients, and the
numerous roles of serotonin in platelet aggregation and activation [11] and kynurenine in
immunomodulation [21], Receiver Operating Curve analyses were performed to assess their
prognostic utility. The higher performing AUC of serotonin (AUC = 0.80, 95% C.I. 0.68–0.92,
p = 0.0002) shows its prognostic superiority compared to kynurenine (AUC = 0.72, 95% C.I.
0.57–0.86, p = 0.008) (S6A and S6B Fig), and was henceforth selected as a better prognostic bio-
marker for DHF.
To improve on serotonin predictive ability and extend the scope of capturing inflammatory
compounds in dengue infections as prognostic biomarkers of DHF, we performed multiplex
immunoassays on 27 cytokines/chemokines. Nine were significantly different between DF and
DHF namely, IFN-γ, IL-1β, IL-4, IL-8, G-CSF, MIP-1β, FGF basic, TNFα and RANTES (S7
Fig). VIP plots generated from OPLS-DA modelling revealed IFN-γ as the top ranked cytokine
in dengue infections (S8A Fig). The importance of IFN-γ as a prognostic biomarker is consis-
tent with it being widely reported as an important pro-inflammatory cytokine in dengue
[22,23]. In addition, due to reports of the elevation of IL-10 in DHF patients, IL-10 has been
suggested as a biomarker of severe dengue [24,25]. We compared the DHF prediction potential
for IFN-γ alone, IL-10 alone, platelets alone, and the combination of serotonin and IFN-γ at
<96 h from onset of fever. The AUCs of platelets, serotonin alone, IFN-γ alone and IL-10
alone were 0.78 (95% C.I. 0.66–0.90, p = 0.0001), 0.80 (95% C.I. 0.68–0.92, p = 0.0002), 0.88
(95% C.I. 0.79–0.97, p<0.0001), and 0.55 (95% C.I. 0.40–0.69), respectively (S8B and S8C Fig).
We combined serotonin and IFN-γ which resulted in AUC of 0.92, sensitivity = 77.8% and
specificity = 95.8% (p<0.0001; Fig 5) in predicting DHF.
Discussion
Through a combined untargeted and targeted metabolomics screen in dengue patients, we
have identified depressed levels of circulating serotonin in DF and DHF patients. Lower seroto-
nin levels in DF patients have been observed previously and are consistent with our study [26].
Our study thus extended on previous knowledge by demonstrating that the declines of serum
serotonin are steeper in DHF patients compared to DF patients in the febrile phase and this
declining trend continues into the defervescence phase. Due to early drop in circulating seroto-
nin within the first 96 h from onset of fever, we propose that serotonin, and the inclusion of
cytokines, such as IFN-γmay be used as prognostic biomarkers for the early prognosis of DHF.
Circulating serotonin forms a distinct pool separate from central nervous system serotonin
pool, and is taken up via SERT and stored in platelets. During platelet aggregation, platelet-
stored serotonin is released into circulation [27], which in turn promotes platelet aggregation
in a feedback fashion via the serotonin receptor (5-HT2A) on platelets [28]. It has been shown
that sera from DHF patients cross-react with platelets and inhibit platelet aggregation due to
the auto-antibodies directed against DENV nonstructural protein 1 (NS1) [29,30]. Anti-NS1
antibodies bind to platelet membrane protein disulfide isomerase (PDI) [31]. Moreover, these
anti-NS1 autoantibodies induce platelet lysis [30]. Given that systemic NS1 protein levels cor-
relate with viremia and dengue severity [32,33], it is conceivable that attenuated platelet aggre-
gation and numbers in dengue patients may have resulted in the depressed serum serotonin
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levels and even more so in DHF patients. In addition, animal models and human ex vivo stud-
ies have shown that NS1 cross-reacts with platelets and endothelial cells and reduce platelet
aggregation through the generation of auto-anti-platelet antibodies [30,31,34]. Notably, similar
levels of HTP, the precursor and HIAA, the main metabolite of serotonin, were found in DF
and DHF, suggesting aberrations in the release and/or uptake of serotonin rather than alter-
ations in serotonin metabolism. The targeting of SERT by serotonin-selective reuptake inhibi-
tors (SSRIs) which inhibit the uptake and storage of platelet-serotonin is known to decrease
platelet aggregation responses and consequently increase bleeding time [35]. Indeed, plasma
leakage is the defining feature of severe dengue [14] and platelets are critical in maintaining the
integrity of the vascular system. The steeper declines in serum serotonin in DHF patients in
both febrile and defervescence phases suggest why plasma leakage occurs in DHF patients
rather than DF patients. Therefore, our study provides mechanistic clues to how thrombocyto-
penia, steep serotonin decrease and plasma leakage may be linked in severe dengue.
In dengue, the mechanisms leading to thrombocytopenia are poorly understood and could
occur via several modes, including peripheral platelet destruction by the host immune system
[6,36–38], bone marrow aplasia [39], aberrant platelet function or signaling [6], or all of the
above. Recent studies reveal that platelets participate in inflammation by influencing adaptive
immunity through interactions with monocytes, neutrophils and endothelial cells [8,40]. In
addition several studies have suggested its role in maintaining patent capillary barrier. In
experimental models, platelets adhere to endothelial cells infected with DENV2 [41], and
Fig 5. Receiving Operating Curve of combined serum serotonin and IFN-γ. Values indicate prediction performance for DHF. Green, serotonin only; blue,
IFN-γ only; yellow, platelets only and red, serotonin and IFN-γ. The receiver operating characteristic (ROC) curve plot is a plot of the true positive rate
(sensitivity) against the false positive rate (1—specificity) for the different possible cutpoints of a prognostic test, and provides a useful metric to compare
different indicator variables (biomarkers). An area under the ROC curve (AUC) value close to 1 indicates an excellent prognostic test, a curve that lies close
to the diagonal (AUC = 0.5) has no information content and therefore no prognostic utility. Amongst various sera metabolites and cytokines, the highest AUC
value (0.92) was the combination of serotonin and IFN-γ.
doi:10.1371/journal.pntd.0004607.g005
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directly interact with monocytes and neutrophils [42]. Neutrophils recruited to injured vessels
under pathogenic inflammatory conditions selectively capture activated platelets [43]. In
humans, platelets were reported to form platelet-leukocyte and platelet-monocyte aggregates
[44]. Serotonin is cross-linked to a variety of platelet surface adhesion proteins and clotting fac-
tors [45,46] required for platelet aggregation and interaction with other cell types. It is not
clear, however, how diminished serotonin in DF and DHF patients affects these platelet-cell
interactions.
Given the more rapid decline in serum serotonin in DHF patients compared to DF patients
as early as 96 h after fever onset, we propose serum serotonin as a predictive marker of severe
dengue prognosis. We and others previously identified IFN-γ as a candidate early prognosis
biomarker [22,47] and we integrated serotonin and IFN-γ to achieve early prediction of
patients likely to develop DHF at sensitivity of 77.8% and specificity of 95.8% within 96 h of
fever onset. Our proposed serotonin with IFN-γ duplex biomarker panel attained the same
prognostic performance of 0.92 compared to an eight feature panel previously identified [47].
This may simplify prognosis in a clinical setting. Serotonin and IFN-γ reflects the pathobiology
of dengue-mediated thrombocytopenia and systemic inflammation respectively, and this infor-
mation makes these candidate biomarkers biologically significant and plausible in their reflec-
tion of the pathognomonic symptoms of severe dengue. In this study, we show that serotonin
levels in DHF declined more than DF patients in the febrile phase and continued to stay sup-
pressed in the defervescence phase. Using circulating serotonin as a dengue prognosis bio-
marker appears to have its benefits–we demonstrated that its levels and association with
thrombocytopenia in dengue is independent of whether the infection is primary or secondary.
Future technological developments into rapid and cheaper analytical methods of serotonin and
IFN-γ levels may facilitate early prognosis even in dengue-endemic, resource-poor areas lack-
ing laboratory facilities, although the predictive performance of serotonin and IFN-γ needs fur-
ther validation in a separate cohort. Measuring serum serotonin levels in other febrile, acute
infectious disease, as well as in patients infected with different DENV type may aid in further
showing specificity and potential universality of serotonin as a reliable biomarker.
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